Authors/Disclosures
|
|
No disclosure on file |
|
Samuel A. Frank, MD, FAAN
(Beth Israel Deaconess Medical Center/Harvard Medical School)
|
Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel. |
|
Lise Phan, MD
(West Coast Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
David A. Stamler, MD
(Alterity Therapeutics)
|
Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics. |
|
|
No disclosure on file |
|
Francis O. Walker, MD
(Wake Forest University School of Medicine)
|
No disclosure on file |
|
Claudia Testa, MD, PhD
(University of North Carolina at Chapel Hill)
|
Dr. Testa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Tremor Research Group. |
|
|
No disclosure on file |